Herd Immunity from Meningococcal Serogroup C Conjugate Vaccination.
نویسنده
چکیده
Overall, children looked after by local authorities were more than twice as likely to not receive meningococcal C vaccine than children at home (risk ratio 2.17 adjusting for age and district, 95% confidence interval 2.06 to 2.28, Mantel-Haenszel method). Because universal childhood meningococcal C vaccination was introduced recently, we were able to study the effectiveness of public care without bias from historical health neglect. Although sampling was opportunistic, our findings are likely to be generalisable as immunisation indices for children in public care in the districts surveyed all fell within one standard deviation of the national mean. We did not examine the reasons for failure to immunise. However, during 2001, 16% of children in public care moved placement more than three times. This instability creates potent risk factors, including missed school based immunisation and discontinuity of primary care. The reversed risk ratio for young children in some districts may reflect greater stability in their placements, primary care organisation of the preschool campaign, or targeting of vulnerable children by health visitors. We suggest two ways forward. Firstly, health services should be made accountable for immunisation uptake as well as social services. Secondly, effective shared information systems between health and social services need to be introduced. Together these measures would better protect our most vulnerable children from disease.
منابع مشابه
Meningococcal Serogroup A, C, W135 and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
BACKGROUND In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was introduced in the Netherlands for all children aged 14 months. Despite its success, herd immunity may wane over time. Recently, a serogroup A,C,W135,Y meningococcal conjugate vaccine (MenACWY) was licensed for use in subjects of 12 months of age and above. OBJECTIVES To evaluate the cost-effectivenes...
متن کاملImpact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
BACKGROUND In 1999, meningococcal serogroup C conjugate (MCC) vaccines were introduced in the United Kingdom for those under 19 years of age. The impact of this intervention on asymptomatic carriage of meningococci was investigated to establish whether serogroup replacement or protection by herd immunity occurred. METHODS Multicenter surveys of carriage were conducted during vaccine introduct...
متن کاملDynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.
Much interest has surrounded the use of conjugate vaccines in recent years, with the development of vaccines against disease caused by Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae. These vaccines offer the potential for safe and effective disease control, but some questions remain, particularly regarding the duration and mechanisms of protection and the lo...
متن کاملEconomics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
BACKGROUND In June 2005, the Advisory Committee on Immunization Practices recommended the newly licensed quadrivalent meningococcal conjugate vaccine for routine use among all US children aged 11 years. A 1-time catch-up vaccination campaign for children and adolescents aged 11-17 years, followed by routine annual immunization of each child aged 11 years, could generate immediate herd immunity ...
متن کاملVaccines for the unvaccinated: protecting the herd.
Interrupting the transmission of infectious agents by introducing new vaccines into a population and creating herd immunity has proven to be a remarkable hidden genie for vaccine effectiveness. For example, oneto two-thirds of the effectiveness of the bacterial conjugate vaccines is linked to protection of the unvaccinated. However, the mechanisms of herd immunity are often not well understood,...
متن کاملMeningococcal conjugate vaccines: optimizing global impact
Meningococcal conjugate vaccines have several advantages over polysaccharide vaccines, including the ability to induce greater antibody persistence, avidity, immunologic memory, and herd immunity. Since 1999, meningococcal conjugate vaccine programs have been established across the globe. Many of these vaccination programs have resulted in significant decline in meningococcal disease in several...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BMJ
دوره 326 7385 شماره
صفحات -
تاریخ انتشار 2003